Women's Health News

RSS

Ovarian cancer tissue and healthy tissue smell different

György Horvath from the University of Gothenburg, Sweden, and researchers from the University of Gävle and KTH Royal Institute of Technology have been able to confirm in tests that ovarian cancer tissue and healthy tissue smell different. The results were published recently in the journal Future Oncology.

21 Dec 2010

Mums urged not to delay births for leave scheme

Many Australian couples are delaying having a baby in order to access the federal government’s paid parental leave scheme. The scheme begins at the start of the New Year and allows eligible parents to access up to 18 weeks pay at the minimum wage. Figures show that from January 1, 2011 an estimated 148,000 families will be eligible to receive a payment of $570 a week before tax, or $10,260 over 18 weeks.

20 Dec 2010

AAPD pediatric oral health experts partner with text4baby to provide information to pregnant women, new moms

The American Academy of Pediatric Dentistry (AAPD), the recognized leader in children's oral health, announced today an outreach partnership with the text4baby program. The AAPD's leading pediatric oral health experts will work closely with text4baby in the dissemination of information to pregnant women and new moms about children's oral health care.

20 Dec 2010

New U.N. commission will track donors' pledges on maternal, child health

Canadian Prime Minister Stephen Harper and Tanzanian President Jakaya Kikwete will co-chair a new "U.N. commission tasked with tracking whether $40 billion in pledges from countries and aid groups are really flowing to efforts to improve the health of mothers and young children in poor countries, and what impact the programs have," the Globe and Mail reports (Clark, 12/16).

20 Dec 2010

FDA moves to curb Avastin's approval for breast cancer

The Food and Drug administration on Thursday revoked its approval of Roche drug Avastin for the treatment of breast cancer. The agency's action, based on findings that did not confirm that the medicine helped patients with this disease, has drawn criticism from patients and politicians.

20 Dec 2010

U.N. Security Council adopts resolution to ramp up fight against sexual violence

U.N. Secretary General Ban Ki-moon on Thursday "called on the U.N. Security Council to make combating sexual violence a 'top priority'" during the opening of a two-day meeting of the 15-member Council on women, peace and security, Xinhua/People's Daily Online reports (12/17).

20 Dec 2010

Social Security's long-term impact on women's financial security

Without Social Security, research indicates that about half of women age 65 and older would be living in poverty. With the program in place, the poverty rate for women falls to 12 percent. These facts - paired with recommended future courses of action - are presented in the latest installment of the Public Policy & Aging Research Brief series from the National Academy on an Aging Society, the public policy branch of The Gerontological Society of America (GSA).

17 Dec 2010

FDA's decision on Avastin will take away choice for many patients, says Breastcancer.org

Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.

17 Dec 2010

Genentech confirms EMA, FDA updates on Avastin for metastatic breast cancer

Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:

17 Dec 2010

Human fetal immune system entirely different from adult immune system

UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment.

17 Dec 2010

Genetic biomarker linked to increased risk for breast cancer found in 'junk' DNA

A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual's "junk" (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.

17 Dec 2010

Study: Biomarkers may aid in early diagnosis of breast cancer

Using a new, powerful method for rapidly screening molecules associated with disease, proteomics expert Joshua LaBaer and colleagues from the Biodesign Institute at Arizona State University have identified a broad panel of 28 early predictors, or biomarkers, that may one day aid in the early diagnosis of breast cancer.

17 Dec 2010

Repros prepares for dosing 3 mg cohort in low dose Proellex study in uterine fibroids and endometriosis

Repros Therapeutics Inc. today announced it has commenced preparation for dosing the 3 mg cohort in the Company's low dose study of Proellex® following a safety review of data from women that have completed 8 weeks of treatment at a 1 mg dose. No signals of liver toxicity were detected to date in the 1 mg group. Unexpectedly, low levels of drug activity were detected in this first cohort. The Company plans to commence dosing of the second group, 3 mg Proellex, next week.

17 Dec 2010

Bayer's SAFYRAL oral contraceptive receives FDA approval

Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets). In women who choose an OC for birth control, SAFYRAL raises folate levels for the purpose of reducing the risk of rare neural tube defects (NTDs) in a pregnancy conceived while taking SAFYRAL or shortly after discontinuing it.

17 Dec 2010

FDA recommends removal of breast cancer indication from Avastin label

The U.S. Food and Drug Administration announced today that the agency is recommending removing the breast cancer indication from the label for Avastin (bevacizumab) because the drug has not been shown to be safe and effective for that use.

17 Dec 2010

Over quarter million women who gave birth in hospitals had pre-existing diabetes or developed gestational diabetes

More than a quarter million women who gave birth in U.S. hospitals in 2008 had pre-existing diabetes or developed it during their pregnancy - a condition called gestational diabetes, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. This equals 6.4 percent of the 4.2 million women who gave birth in that year.

17 Dec 2010

Researchers discover allium vegetable consumption may lower hip osteoarthritis

Researchers at King's College London and the University of East Anglia have discovered that women who consume a diet high in allium vegetables, such as garlic, onions and leeks, have lower levels of hip osteoarthritis

16 Dec 2010

Affordable Care Act provisions will increase breastfeeding among working mothers

Millions of working mothers were not able to express breast milk while at work until the Affordable Care Act of 2010 (ACA). The law requires employers to provide nursing breaks and a private, sanitary place to express breast milk for most mothers employed on an hourly basis. The ACA provisions for breastfeeding cover three-fifths of employed women living in families below 350 percent of the government poverty line (about $50,000 for a family of two).

16 Dec 2010

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.

16 Dec 2010

Study demonstrates BRACAnalysis testing for women with breast carcinoma in situ

Myriad Genetics, announced today that an article entitled "Prevalence of BRCA1 and BRCA2 Mutations In Women With Carcinoma In Situ of the Breast Referred for Genetic Testing" will appear in the December 2010 issue of the journal Cancer Prevention Research.

16 Dec 2010

Women's Health News

Ovarian cancer tissue and healthy tissue smell different

Mums urged not to delay births for leave scheme

AAPD pediatric oral health experts partner with text4baby to provide information to pregnant women, new moms

New U.N. commission will track donors' pledges on maternal, child health

FDA moves to curb Avastin's approval for breast cancer

U.N. Security Council adopts resolution to ramp up fight against sexual violence

Social Security's long-term impact on women's financial security

FDA's decision on Avastin will take away choice for many patients, says Breastcancer.org

Genentech confirms EMA, FDA updates on Avastin for metastatic breast cancer

Human fetal immune system entirely different from adult immune system

Genetic biomarker linked to increased risk for breast cancer found in 'junk' DNA

Study: Biomarkers may aid in early diagnosis of breast cancer

Repros prepares for dosing 3 mg cohort in low dose Proellex study in uterine fibroids and endometriosis

Bayer's SAFYRAL oral contraceptive receives FDA approval

FDA recommends removal of breast cancer indication from Avastin label

Over quarter million women who gave birth in hospitals had pre-existing diabetes or developed gestational diabetes

Researchers discover allium vegetable consumption may lower hip osteoarthritis

Affordable Care Act provisions will increase breastfeeding among working mothers

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

Study demonstrates BRACAnalysis testing for women with breast carcinoma in situ

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News